Ask me later
Ask me later
How likely are you to recommend Redeye to a friend or colleague?
1
2
3
4
5
6
7
8
9
10
Not likely
Very likely
Not likely
1
2
3
4
5
6
7
8
9
10
Very likely
Thanks again for rating us!
Cantargia: Video interview with CEO Göran Forsber
Research Interview
2023-05-17
08:37
Redeye interviews Göran Forsberg about the new clinical development strategy for nadunolimab in pancreatic cancer with a controlled phase IIb trial instead of participating in Precision Promise.
RR
Richard Ramanius
Disclosures and disclaimers